BridgeMD
New treatment option for Postoperative Complications
Official title Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
ClinicalTrials.gov ID: NCT06777758
What this study is testing
What is Remimazolam?
Remimazolam is an investigational medicine, being studied as a potential treatment for postoperative complications.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to evaluate the efficacy and safety of Remimazolam, either used alone or in combination with Propofol, for moderate sedation anesthesia during endoscopic therapies or examinations. Additionally, it seeks to explore whether their combination can further enhance the quality of patient anesthesia and recovery outcomes.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 80
You may be able to join if
- people are between 20-80 years old.
- Anesthesiologists rated ASA as between I and III.
- Patients undergoing upper gastrointestinal endoscopic examination or therapy.
You likely can't join if
- Allergy to Propofol, Remimazolam, or opioid medications.
- Emergency surgery.
- Pregnancy.
- History of malignant hyperthermia.
- Impaired liver or kidney function.
- Airway difficulties due to pharyngeal tumors.
See the full eligibility criteria
- people are between 20-80 years old.
- Anesthesiologists rated ASA as between I and III.
- Patients undergoing upper gastrointestinal endoscopic examination or therapy.
- Allergy to Propofol, Remimazolam, or opioid medications.
- Emergency surgery.
- Pregnancy.
- History of malignant hyperthermia.
- Impaired liver or kidney function.
- Airway difficulties due to pharyngeal tumors.
- Refusal to participate.
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, Taiwan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.